KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stryker (SYK) Cash & Equivalents (2016 - 2026)

Stryker has reported Cash & Equivalents over the past 18 years, most recently at $2.9 billion for Q1 2026.

  • Quarterly Cash & Equivalents rose 24.05% to $2.9 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.9 billion through Mar 2026, up 24.05% year-over-year, with the annual reading at $4.0 billion for FY2025, 9.83% up from the prior year.
  • Cash & Equivalents was $2.9 billion for Q1 2026 at Stryker, down from $4.0 billion in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $4.0 billion in Q4 2025 and troughed at $1.0 billion in Q2 2022.
  • The 5-year median for Cash & Equivalents is $2.3 billion (2025), against an average of $2.4 billion.
  • Year-over-year, Cash & Equivalents crashed 53.41% in 2022 and then surged 106.99% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $1.8 billion in 2022, then soared by 61.12% to $3.0 billion in 2023, then rose by 22.92% to $3.7 billion in 2024, then increased by 9.83% to $4.0 billion in 2025, then dropped by 28.25% to $2.9 billion in 2026.
  • Per Business Quant, the three most recent readings for SYK's Cash & Equivalents are $2.9 billion (Q1 2026), $4.0 billion (Q4 2025), and $3.3 billion (Q3 2025).